Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 44 Neoplasms 43 Lung Neoplasms 28 Colorectal Neoplasms 21 Carcinoma, Non-Small-Cell Lung 20 Prostatic Neoplasms 15 Ovarian Neoplasms 15 Pancreatic Neoplasms 13 Melanoma 11 Uterine Cervical Neoplasms 10 Neoplastic Cells, Circulating 9 Neoplasm Metastasis 9 Sarcoma 8 Multiple Myeloma 8 Head and Neck Neoplasms 8 Glioma 8 Glioblastoma 8 Hematologic Neoplasms 7 Colonic Neoplasms 7 Carcinoma, Hepatocellular 7 Lymphoma 6 Leukemia, Myeloid, Acute 6 Endometrial Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Gastrointestinal Neoplasms 5 Disease 5 Brain Neoplasms 5 Urinary Bladder Neoplasms 4 Rectal Neoplasms 4 Peritoneal Neoplasms 4

Interventions

testosterone undecanoate 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 Gonadotropins 1 Diet, Protein-Restricted 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Prostate Cancer Recurrent × Blood Specimen Collection × Clear all

NCT04324983 2023-04-12

BioPoP

Martini-Klinik am UKE GmbH

Phase NA Completed

Prostate Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡